BioSpace News Archive

The evidence-based guidelines were developed in collaboration by the CAP, the IASCL, the AMP and the ASIP.

The treatment method is the technology underlying the RenovaCare patented SkinGun and CellMist System.

Waters Corporation today introduced the Waters ACQUITY Arc Bio System, a versatile, iron-free, bio-inert, quaternary liquid chromatograph specifically engineered to enable the efficient transfer and improvement of bioseparation analytical methods regardless of the LC platform on which the original method was developed.

OARtrac provides critical radiation dose feedback which helps facilitate adaptive radiotherapy for true personalized treatment with the goal to reduce side effects and offer better clinical outcomes.

In addition, trials in California over the last two years show that Haven applications resulted in significantly higher almond and walnut yields, compared to competing products.

WIN lingual braces work in the same way as conventional fixed braces, with full control and movement of the teeth, but they are invisible from the outside.

The FDA grants orphan drug status to promote the development of novel products to treat conditions affecting fewer than 200,000 people in the United States.

Monarch Medical Technologies today announced that the company will host a complimentary webinar, “Beyond Sliding Scale: Closing the Gap Between Current and Optimal Glycemic Management Practices” on February 13, from 1-2 p.m. EST.

MedX Health Corp. is pleased to announce that it received an initial order in excess of $100,000 for its pain-free, non-invasive skin assessment SIAscopy technology for use in Spain through its marketing partnership with OncoTech LLC.

This is a Phase II prospective, multicenter, single arm, open label study designed to assess the safety and efficacy of GA Depot in delaying the accumulation of disability in subjects with PPMS.